| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |